This CPD activity is sponsored by Reckitt. All content is the true, accurate and independent opinion of the speakers and the views expressed are entirely their own.[/caption]
Sources: Australasian College of Pharmacy. Management of reflux: a guideline for pharmacists. Queensland Health. Queensland Community Pharmacy Gastro-oesophageal Reflux and Gastro-oesophageal Reflux Disease – Clinical Practice Guideline. NSW Health. NSW Pharmacist Practice Standards for gastro-oesophageal reflux and gastro-oesophageal reflux disease.[/caption]
Dr Ming S Soh PhD, BPharm (Hons)[/caption]
DR Amy Page (she/her) PhD, MClinPharm, GradDipBiostat, GCertHProfEd, GAICD, GStat, FSHPA, FPS is a consultant pharmacist, biostatistician, and the director of the Centre for Optimisation of Medicines at UWA’s School of Allied Health.[/caption]
Hui Wen Quek (she/her) BPharm(Hons), GradCertAppPharmPrac is a pharmacist and PhD candidate at the University of Western Australia (UWA).[/caption]
Take-home naloxone: How to ensure you save a life
In the pilot phase of the The national Take Home Naloxone (THN) program, ‘three lives were saved each day’, and it is expected that an even greater impact will be seen with the national rollout.
Helping high-risk holidaymakers
Highest risk travellers need additional support from pharmacists, particularly those who are visiting friends and relatives.
Pharmacological interventions for managing acute pancreatitis
The prevalence of acute pancreatitis is between 5 and 30 per 100,000 population worldwide. It also represents the most common cause for gastrointestinal hospital...
From hocus pocus to quality use of medicines
University of South Australia Emeritus Professor Lloyd Sansom AO FPS has led improvements in the quality use of medicines in Australia and internationally.
When...
COVID-19 rollout strategy recalibrated
Pfizer is now the COVID-19 vaccine of choice for some at-risk patients and those under 50 years of age in priority groups.
NIP access (almost) guaranteed
The state's major parties have committed to allowing pharmacist immunisers to access the National Immunisation Program (NIP) for the first time.
